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Abstract
Little is known about validity of self-reported mammography surveillance among breast cancer 
survivors. Most studies have focused on accuracy among healthy, average-risk populations and 
none have assessed validity by electronic medical record (EMR) extraction method. To assess 
validity of survivor-reported mammography post-active treatment care, we surveyed all survivors 
diagnosed 2004–2009 in an academic hospital cancer registry (n = 1441). We used electronic 
query and manual review to extract EMR data. Concordance, sensitivity, specificity, positive 
predictive value, and report-to-records ratio were calculated by comparing survivors' self-reports 
to data from each extraction method. We also assessed average difference in months between 
mammography dates by source and correlates of concordance. Agreement between the two EMR 
extraction methods was high (concordance 0.90; kappa 0.70), with electronic query identifying 
more mammograms. Sensitivity was excellent (0.99) regardless of extraction method; concordance 
and positive predictive value were good; however, specificity was poor (manual review 0.20, 
electronic query 0.31). Report-to-records ratios were both over 1 suggesting over-reporting. We 
observed slight forward telescoping for survivors reporting mammograms 7–12 months prior to 
survey date. Higher educational attainment and less time since mammogram receipt were 
associated with greater concordance. Accuracy of survivors' self-reported mammograms was 
generally high with slight forward telescoping among those recalling their mammograms between 
7 and 12 months prior to the survey date. Results are encouraging for clinicians and practitioners 
relying on survivor reports for surveillance care delivery and as a screening tool for inclusion in 
interventions promoting adherence to surveillance guidelines.
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The number of US breast cancer survivors is rapidly increasing (>2.85 million in 2010 [1]) 
with significant numbers diagnosed at early stages. Post-active treatment surveillance with 
mammography is recommended to detect recurrent and new primary cancers early and 
improve survival [2–5]. Despite its demonstrated benefits, adherence is suboptimal (ranging 
from 53 to 92 % [6–13]), although estimates are wide ranging and depend in part on data 
source (e.g., self-report, claims data, medical record). From a cancer control research 
perspective, a valid self-report measure of mammography surveillance is important for 
identification of correlates/predictors, appropriate triage of survivors who would benefit 
from interventions promoting post-treatment surveillance, evaluation of intervention trials, 
and assessment of trends in adherence to guidelines [14, 15]. Providers caring for breast 
cancer survivors also need information on the accuracy of self-reported behavior in order to 
make timely recommendations. While there is a large literature documenting the accuracy of 
self-reported mammography among healthy women; [16, 17] little is known about the 
accuracy of breast cancer survivors' reports [18].
To evaluate validity and reliability of self-reported behavior, studies have used a variety of 
data sources as the gold standard including administrative claims, computerized radiology 
databases, and paper/electronic medical records; some studies have even combined 
administrative and medical record data [16, 19]. Several have argued that administrative 
claims data are not as precise as clinical data gleaned from manual abstraction of paper 
medical records [20]. It is less clear if this caveat is also true with electronic medical records 
(EMR), which is important given increasing adoption in US. Approximately, 34 % of 
physician offices had EMR systems in 2011 [21] and the number is likely to grow with 
federal initiatives encouraging EMR adoption [22]. An advantage of EMRs is the ability to 
use computer programmers to extract data which significantly reduces time and cost. With 
federal initiatives encouraging the meaningful use of EMRs [22, 23], researchers should 
examine performance of different EMR extraction methods.
This study was designed to accomplish three aims: (1) examine concordance and kappa 
between two methods of EMR data extraction: electronic query and manual review; (2) 
evaluate the concordance, sensitivity, specificity, positive predictive value, and report-to-
records ratio of breast cancer survivors' self-reported most recent mammogram with EMR 
data extracted via electronic query and manual review; and (3) identify correlates of 
concordance between survivors' report and the EMR.
 Methods
Data were collected as part of a larger study on breast and colorectal cancer survivors. 
Recruitment methods, participants, and data collection for the patient survey have been 
previously described [24]. Breast cancer survivors with stage 0–III disease diagnosed 
between 2004 and 2009 (N = 1441) and listed in an academic hospital cancer registry were 
invited to complete a survey between July and December 2011. The response rate was 
31.4 % (n = 452). Based on survey responses, we excluded patients who (1) did not report at 
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least the year of the most recent mammogram (n = 3); (2) reported a mammography date in 
the future relative to the survey date (n = 7); or (3) reported bilateral mastectomies (n = 70) 
because post-treatment mammography screenings are not recommended for this subgroup. 
The final analytic sample was 372.
The hospital and outpatient clinics (primary care, radiology, oncology) in the academic 
medical center all use the same EMR (EpicCare; Verona, WI). Mammography data from the 
EMR were obtained through two methods: manual review by three trained non-physician 
research assistants (RAs) and an electronic query of the hospital data warehouse.
 Outcome measures
 Patient self-report—Breast cancer survivors answered the following survey question: 
“What was the month and year of your most recent mammogram?”
 Electronic query—We requested a report from the Clinical Information Systems (CIS) 
team at the academic medical center that electronically queried the hospital data warehouse. 
The hospital data warehouse contains claims- and procedure-based EMR data directly 
downloaded from the EpicCare EMR system. The date of all mammograms between January 
1, 2010 and December 1, 2011 for each survivor was extracted.
 Manual review—RAs used an abstraction form to manually extract from the survivor's 
EMR all mammography dates between January 1, 2010 and December 1, 2011 as well as the 
location where data were stored. RAs systematically looked in three locations: imaging, 
progress notes of encounters, and media reports. The latter was where clinical staff uploaded 
digital copies of mammograms received outside the healthcare system. We also used manual 
review to identify and exclude survivors receiving bilateral or two separate mastectomy 
procedures (i.e., in effect a bilateral mastectomy but not at the same time). RAs were blinded 
to survivors' self-reported mammogram status. A 10 % random sample of survivors was 
reviewed as a quality control check and had 100 % agreement on mammography month and 
year.
 Receipt of a recent mammogram—For each data source (survivor self-report, 
electronic query, manual review), we used the date survivors reported completing the survey 
(hereafter survey date) to calculate whether or not the survivor had a mammogram within the 
past 12 months. We chose a 12-month interval because survivors varied in the time since 
completing active treatment; thus, at a minimum, all were recommended to get a 
mammogram at least every year [2–5]. For each data source, we coded the patient as having 
had a recent mammogram (1 = yes) if the mammogram month and year were within 13 
months of the survey date; otherwise, the survivor was coded as 0 (no recent mammogram).
 Other variables of interest
Sociodemographic variables included survivor-reported age, sex, race/ethnicity, marital 
status, and education. If date of birth was missing or unclear, we calculated age based on the 
birth date documented in the cancer registry (the data source from which the survey sample 
was selected). We also queried the cancer registry for the number of years since cancer 
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diagnosis. Healthcare access and utilization variables including insurance, receipt of follow-
up care in 2010 and 2011, and type of provider seen for follow-up care were obtained 
through the survey.
 Data analysis
To examine agreement between the two EMR data extraction methods for ascertaining 
recent post-treatment mammography (Aim 1), we compared electronic query to manual 
review and calculated concordance (proportion of survivors with agreement between two 
sources of data) and kappa as there is no gold standard for how to collect EMR data.
To evaluate the validity of survivors' self-report by EMR extraction method (Aim 2), we 
compared self-report versus manual review and self-report versus electronic query. We 
calculated point estimates and 95 % confidence intervals (CIs) for the following validity 
measures: concordance, sensitivity (proportion of survivors who self-reported a 
mammogram within the past 13 months among those with one documented in the EMR), 
specificity (proportion of patients who reported not having a mammogram in the past 13 
months among those without a mammogram in the EMR), positive predictive value 
(proportion of survivors who had one documented in the EMR among those who self-
reported a recent mammogram), and report-to-records ratio (percentage of self-reported 
mammograms divided by the percentage of mammograms documented in the EMR). If the 
report-to records ratio is greater than 1, then the estimate suggests a pattern of over-reporting 
recent mammograms by survivors. We estimated sensitivity to assess under-reporting and 
specificity, positive predictive value, and report-to-records ratio to examine over-reporting.
We used Tisnado et al.'s criteria for evaluating concordance, sensitivity, and specificity of 
ambulatory care services: ≥0.9 indicates excellent agreement, ≥0.8 to<0.9 indicates good 
agreement, ≥0.7 to <0.8 indicates fair agreement, and <0.7 indicates poor agreement [25].
For the subset of women who reported a mammogram month and year in the 13 months 
prior to the survey date and had mammogram dates available through electronic query, we 
also computed the average difference in months between survivors' self-report and the EMR 
data to examine telescoping (survivors perceiving the mammography event to be more 
distant or more recent than it actually was) and stratified estimates by recency of the 
mammogram relative to the survey date [26].
To evaluate correlates of concordance (Aim 3), we ran univariate logistic regression models 
with the concordance outcome variable comparing self-report to the EMR extraction method 
that yielded the most comprehensive mammography data.
 Results
In our final analytic sample of 372 breast cancer survivors, most were over age 50, non-
Hispanic White, married or living with a partner, and had private insurance or Medicare 
(Table 1). Based on survey data, 94.1 % of breast cancer survivors reported having a 
mammogram within 13 months of their survey date. Electronic query EMR extraction 
method identified a mammogram within 13 months of their survey date for 84.4 % of the 
Tiro et al. Page 4













survivors. Manual review identified 76.3 % within the same time-frame; 5.6 % (n = 10) of 
the mammograms identified by manual review were only documented in the provider's 
progress note because the mammogram was conducted at a radiology facility external to the 
academic medical center. Concordance between the two extraction methods was 0.90 and 
kappa was 0.70. Among the subset who had mammography dates available through both 
methods (n = 287), the average difference between electronic query and manual review was 
0.8 months (range −4.0 to 14.0 months); dates exactly matched 85 % of the time.
Table 2 shows the point estimates and 95 % CIs for the five validity measures (concordance, 
sensitivity, specificity, positive predictive value, and report-to-records ratio) when comparing 
survivors' self-report to each of the EMR data extraction methods. Based on Tisnado et al.'s 
criteria and regardless of data extraction method, survivors' self-reports showed excellent 
sensitivity (both extraction methods: 0.99), and fair/good agreement for concordance and 
positive predictive value. However, specificity was poor (manual review: 0.20; electronic 
query 0.31); and both report-to records ratios were over 1. Collectively, the estimates for 
specificity, positive predictive value, and re-port-to-records ratio suggest a consistent pattern 
of over-reporting with some survivors reporting a recent mammogram when there was none 
documented in the EMR.
Figure 1 shows the difference in months between self-reported and EMR electronic query 
mammogram dates by recency of survivors' self-reported mammogram date relative to her 
survey date. Most survivors, who reported that they had a mammogram within 3 months and 
4-6 months of the survey date, had no difference with the EMR (71 and 62 %, respectively, 
had an exact month and year match). Survivors who reported a mammogram 7–13 months 
prior to the survey date had slight forward telescoping (e.g., they recalled the mammography 
date to be more recent than documented in the EMR).
Table 3 shows univariate analyses examining correlates of concordance between self-
reported and EMR data. Education and recency of self-reported mammogram were 
associated with concordance. Survivors with a bachelor's degree were more likely to be 
concordant than survivors with a high school degree or less. Survivors who reported a 
mammogram 7–13 months prior or who did not provide the month of the mammogram were 
less likely to be concordant than those who reported a mammogram less than 3 months prior 
to the survey date.
 Discussion
Many studies have considered the accuracy of mammography self-report among the general 
population [16, 17], but few have looked specifically at breast cancer survivors [18]. 
Surveillance guidelines for breast cancer survivors recommend more frequent mammograms 
than for women at average risk for breast cancer; thus, data on the accuracy of survivors' 
self-reports are needed to estimate bias in survey-based screening adherence estimates [16]. 
Similar to studies among average-risk women [16, 17], we found excellent agreement 
between survivors' reports and the EMR for sensitivity and fair/good agreement for 
concordance and positive predictive value; but poor agreement for specificity. Concordance 
and positive predictive value estimates were slightly higher using the electronic query versus 
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manual review EMR extraction method, suggesting more complete extraction of 
mammograms using the electronic query method.
Concordance between the two extraction methods (manual review and electronic query) was 
excellent. Manual review involved using the EpicCare user interface to abstract dates from 
three locations in the survivor's EMR (imaging, progress notes of encounters, and media 
reports); we found documentation of mammograms received at an outside facility for only 
ten survivors. The electronic query, in contrast, involved extracting the same clinical tables 
as from the manual review in addition to extracting tables used to bill for services. 
Therefore, the electronic query cast a wider net, and was able to search for data that even 
trained reviewers cannot view while logged into the EpicCare user interface. When done 
correctly and thoroughly, electronic query of the EMR database could yield more complete 
results than the historical gold standard of manual review. Given the speed and cost savings 
from the electronic query method, our findings suggest that electronic query is the best 
extraction method for EMR databases that access both care delivery and billing data tables.
For clinicians treating breast cancer survivors, accurate self-reports of mammography are 
especially important. Currently, guidelines do not specify whether oncologists or primary 
care physicians should have primary responsibility for promoting mammography 
surveillance [2–4, 27], and there is evidence that many survivors seek care from both types 
of physicians [27, 28]. As such, oncologists and primary care physicians, who have unlinked 
EMRs and need to coordinate care, may find it challenging to verify mammography receipt 
and may rely on survivor self-report. Our findings of good agreement between survivor self-
reported mammography and EMR (regardless of extraction method) should help clinicians 
feel comfortable trusting reports from breast cancer survivors particularly those who report 
having a mammography in the past 6 months. For these patients, the concordance is 
excellent. Concordance rates between survivors' reports and the EMR are lowest among 
those reporting a mammography 7–12 months prior to the survey data and those who did not 
report a date. Thus, clinicians seeing new patients who report a mammography date over 
than 6 months ago may want to verify mammography dates by contacting radiology 
facilities.
Our findings of poor specificity are similar, but more pronounced than studies among 
average-risk women [16, 17]. This indicates that some survivors are either falsely reporting a 
recent mammogram or may have had a mammogram that was not reflected in the EMR (e.g., 
at another radiology facility). Figure 1 suggests forward telescoping among survivors 
reporting mammogram dates 7–12 months prior to the survey date (i.e., some women are 
reporting that their mammogram was more recent in time than it actually was). Forward 
telescoping and over-reporting may occur because survivors' perceive mammograms to be 
socially desirable [29]. Our validity analyses assumed that the EMR, regardless of the 
extraction method, is the gold standard; yet it is possible that the EMR may not be up-to-
date, particularly for mammograms received outside of the treating facility.
Breast cancer survivors, in general, and those represented in this study, use mammography at 
higher rates than women in the general population. In our sample, the EMR indicated that 
more than 80 % of the women were adherent with mammography surveillance guidelines. 
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This high adherence rate may be a product of treatment in an academic medical center, or 
the fact that over two-thirds of the women report being followed by their oncologist. 
Although practice guidelines recommend annual surveillance mammography [2–5], many 
survivors are not adherent; this is particularly true of older survivors [6, 8] and those seen by 
primary care physicians [27, 30].
The following study limitations should be considered. Breast cancer survivors who 
participated in this study are all associated with an academic medical center; thus, they may 
not be representative of survivors treated in community practice settings. Also, the hospital 
and outpatient clinics (oncology, radiology, internal medicine, and family practice) share the 
same EMR system; thus, survivors may be more likely to have a mammogram at an internal 
facility and documentation of mammography in the EMR may be more thorough in this type 
of vertically integrated healthcare system. While EpicCare is the most widely used EMR 
system across the US, there are several other competitors and they may store mammography 
data differently. Future studies should examine the accuracy of survivors' reports and 
adherence rates in community practice settings using different EMR systems and with more 
ethnically diverse survivor populations.
In conclusion, the accuracy of breast cancer survivors' self-reported mammograms was 
generally high with suggestions of some slight forward telescoping among those recalling 
their mammograms between 7 and 12 months prior to the survey date. Results are 
encouraging for clinicians and practitioners who rely on survivor reports for surveillance 
care delivery and as a screening tool for inclusion in interventions promoting adherence to 
surveillance guidelines.
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Fig. 1. Difference in months between self-reported and EMR electronic query mammogram 
dates by recency of self-report relative to survey date among breast cancer surivors who 
reported a recent mammogram (N = 287)
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Table 1
Sociodemographic and healthcare utilization characteristics for breast cancer survivors 
recruited through an academic medical center's cancer registry and responded to a 
mailed survey, 2011 (N = 372)
Characteristics N (%)
Age (years)
 ≤49 35 (9.4)
 50–64 188 (50.5)
 65+ 149 (40.1)
Race/ethnicity
 Hispanic 33 (8.9)
 NH White 270 (72.6)
 NH Black 57 (15.3)
 NH Other 12 (3.2)
Married/live with partner (yes) 243 (65.4)
Education*
 <HS/HS diploma/GED 74 (19.8)
 Some college/technical degree 121 (32.5)
 Bachelor's degree 104 (27.9)
 Graduate degree 74 (19.8)
Insurance status*
 Private/VA 244 (65.5)
 Medicare/medigap 86 (23.1)
 Medicaid/state 31 (8.4)
 None 11 (3.0)
Follow-up care in 2010/11 (yes) 331 (89.0)
Provider type, 2010/2011 follow-up care
 No provider 41 (11.0)
 PCP only 11 (3.0)
 Oncologist only 254 (68.3)
 PCP and oncologist 66 (17.7)
Years since diagnosis
 <5 years 221 (59.4)
 ≥5 years 151 (40.6)
NH Non-Hispanic, HS high school, GED general educational development, VA Veteran's affairs, PCP primary care physician
*
Reduced sample size for married/live with partner (n = 370), education (n = 369), and insurance status (n = 368) due to missing data
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Table 3
Univariate analyses examining correlates of concordance between self-report and EMR 
data extracted via electronic query (N = 372)
Characteristics Total Comparison of SR and EMR was concordant Crude
N n (%) Odds ratio (95 % CI)
Age (years)
 ≤49 35 33 (94.3) 1.00
 50–64 188 164 (87.2) 0.41 (0.09, 1.84)
 65+ 149 131 (87.9) 0.44 (0.10, 2.00)
Race/ethnicity
 NH White 270 243 (90.0) 1.00
 NH Black 57 46 (80.7) 0.46 (0.22, 1.00)
 Hispanic 33 29 (87.9) 0.81 (0.26, 2.47)
 NH other 12 10 (83.3) 0.56 (0.12, 2.67)
Marital status*
 No 128 115 (89.8) 1.00
 Yes 242 212 (87.6) 0.80 (0.40, 1.59)
Education*
 <HS/high school/GED 73 61 (83.6) 1.00
 Some college/Technical degree 120 104 (86.7) 1.28 (0.57, 2.88)
 Bachelor's degree 103 97 (94.2) 3.18 (1.13, 8.92)
 Graduate degree 73 64 (87.7) 1.40 (0.55, 3.56)
Insurance status*
 Private/VA 241 215 (89.2) 1.00
 Medicare/medigap 85 73 (85.9) 0.74 (0.35, 1.53)
 Medicaid/state 31 28 (90.3) 1.13 (0.32, 3.97)
 None 11 9 (81.8) 0.54 (0.11, 2.66)
Follow-up care in 2010–2011
 No 41 34 (82.9) 1.00
 Yes 331 294 (88.8) 1.64 (0.68, 3.95)
Type of provider seen
 No provider 41 34 (82.9) 1.00
 PCP only 11 7 (63.6) 0.36 (0.08, 1.57)
 Oncologist only 254 231 (90.9) 2.07 (0.82, 5.19)
 PCP and oncologist 66 56 (84.8) 1.15 (0.40, 3.31)
Years since diagnosis
 <5 years 221 196 (88.7) 1.00
 ≥5 years 151 132 (87.4) 0.89 (0.47, 1.67)
Recency of self-reported mammogram
 ≤3 months 155 143 (92.3) 1.00
 4–6 months 114 103 (90.4) 0.79 (0.33, 1.85)
 7–9 months 42 33 (78.6) 0.31 (0.12, 0.79)
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Characteristics Total Comparison of SR and EMR was concordant Crude
N n (%) Odds ratio (95 % CI)
 10–13 months 27 21 (77.8) 0.29 (0.10, 0.87)
 >13 months 17 15 (88.2) 0.63 (0.13, 3.08)
 No mammogram month reported 17 13 (76.5) 0.27 (0.08, 0.97)
Bolded odds ratio and estimates indicate significant associations (P < 0.05)
*
Missing data for n = 2 (marital status), n = 3 (education), and n = 4 (insurance) survivors, respectively
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